REXALL FDA Approval ANDA 080637

ANDA 080637

REXALL

FDA Drug Application

Application #080637

Application Sponsors

ANDA 080637REXALL

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL0.25MG0RESERPINERESERPINE

CDER Filings

REXALL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 80637
            [companyName] => REXALL
            [docInserts] => ["",""]
            [products] => [{"drugName":"RESERPINE","activeIngredients":"RESERPINE","strength":"0.25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"RESERPINE","submission":"RESERPINE","actionType":"0.25MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.